Your session is about to expire
← Back to Search
Salsalate for Peripheral Neuropathy (TINSAL-T1DN Trial)
TINSAL-T1DN Trial Summary
This trial will study whether salsalate can help prevent or delay the development of diabetic neuropathy in people with type 1 diabetes.
- Peripheral Neuropathy
- Type 1 Diabetes
TINSAL-T1DN Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTINSAL-T1DN Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TINSAL-T1DN Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are new participants being accepted into this trial at the current time?
"That is correct, the online information indicates that the study is still looking for subjects. The trial was originally posted on October 1st, 2016 and was most recently updated June 1st of this year. They are hoping to enroll 70 individuals at 3 different locations."
Are elderly patients a part of this research program?
"This trial is only taking applications from patients aged 18 to 70. Out of the qualifications trials, this one is for people in the middle-age bracket. There are 256 trials specifically for children and 1391 research studies available for senior citizens."
What is the biggest amount of people who are taking part in this experiment?
"The data on clinicaltrials.gov does show that this study is recruiting patients. The trial was originally posted on October 1, 2016 and the most recent update was on June 1, 2022. They are hoping to enroll 70 people total at 3 different sites."
What is the precedent for Salsalate research?
"At the moment, there are 5 different ongoing studies for Salsalate. 1 of these live trials is in its final stage of testing before commercial release. Even though most research is based out of Ann Arbor, Michigan; there are actually 10 locations running active trials."
Are there specific requirements to be a part of this clinical trial?
"This study is investigating a possible treatment for peripheral neuropathy and is looking for around 70 participants that are between 18 and 70 years old."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger